ABG-WTT Global Life Science Capital Partners GP Ltd
An institutional investment manager in CENTRAL, HONG KONG. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1832108.
- Reported value$8.6m
- Positions2
Holdings: 2 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$k | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Ceribell IncCBLL | COM | 15678C102 | 5,355 | 62.6% | 275,328 | Reduced−166,492 | |
| Rapid Micro Biosystems IncRPID | CLASS A COM | 75340L104 | 3,198 | 37.4% | 1,848,296 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-352439 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.